COVID is the medium term benefit for this company, it gets to show case it’s technology, while others pay for it. The sales team gets out there (slower than normal) and over time will grow the customer base. It really is dependant on how the C team manage sales rollout and allocate capital. Not the short term negativity around a large part of the market at the moment.
COVID is the medium term benefit for this company, it gets to...
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
76.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $172.1M | |||
| Open | High | Low | Value | Volume |
| 76.0¢ | 76.0¢ | 76.0¢ | $47.45K | 62.43K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29990 | 75.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 76.0¢ | 18639 | 2 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| GSS (ASX) Chart |